قااون
COMPLIANCE FOR BIOPHARMACEUTICAL
Within the EMA, the Committee for Medicinal Products for Human Use (CHMP) performs the actual assessment of the application and issues a scientific opinion.
Learn more
Implementation of the Biosimilar Pathway: Economic and
by H Grabowski 2011 Cited by 64 The European Union has had a well-defined regulatory pathway for biosimilars in place for several years which provides one model that could
Learn more
Patients and Consultants Views and Perceptions on
by DC Rosembert 2024 Cited by 7 The aim of this study was to describe the opinions of patients undergoing treatment with originator biologics and medical consultants managing their conditions.
Learn more